ATE234920T1 - Aktivin-rezeptor-ähnliche kinasen, proteine mit serin/threonin kinase domänen und deren anwendungen - Google Patents

Aktivin-rezeptor-ähnliche kinasen, proteine mit serin/threonin kinase domänen und deren anwendungen

Info

Publication number
ATE234920T1
ATE234920T1 AT93924777T AT93924777T ATE234920T1 AT E234920 T1 ATE234920 T1 AT E234920T1 AT 93924777 T AT93924777 T AT 93924777T AT 93924777 T AT93924777 T AT 93924777T AT E234920 T1 ATE234920 T1 AT E234920T1
Authority
AT
Austria
Prior art keywords
kinases
serine
kinase domain
threonine kinase
proteins
Prior art date
Application number
AT93924777T
Other languages
English (en)
Inventor
Kohei Miyazono
Peter Ten Dijke
Petra Franzen
Hidetoshi Yamashita
Carl-Henrik Heldin
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929224057A external-priority patent/GB9224057D0/en
Priority claimed from GB939304677A external-priority patent/GB9304677D0/en
Priority claimed from GB939304680A external-priority patent/GB9304680D0/en
Priority claimed from GB939311047A external-priority patent/GB9311047D0/en
Priority claimed from GB939313763A external-priority patent/GB9313763D0/en
Priority claimed from GB939316099A external-priority patent/GB9316099D0/en
Priority claimed from GB939321344A external-priority patent/GB9321344D0/en
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of ATE234920T1 publication Critical patent/ATE234920T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93924777T 1992-11-17 1993-11-17 Aktivin-rezeptor-ähnliche kinasen, proteine mit serin/threonin kinase domänen und deren anwendungen ATE234920T1 (de)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB929224057A GB9224057D0 (en) 1992-11-17 1992-11-17 Novel protein kinase receptors
GB939304677A GB9304677D0 (en) 1993-03-08 1993-03-08 Protein kinases
GB939304680A GB9304680D0 (en) 1993-03-08 1993-03-08 Protein kinases
GB939311047A GB9311047D0 (en) 1993-05-28 1993-05-28 Protein kinases
GB939313763A GB9313763D0 (en) 1993-07-02 1993-07-02 Protein kinases
GB939316099A GB9316099D0 (en) 1993-08-03 1993-08-03 Protein kinases
GB939321344A GB9321344D0 (en) 1993-10-15 1993-10-15 Protein kinases
PCT/GB1993/002367 WO1994011502A2 (en) 1992-11-17 1993-11-17 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use

Publications (1)

Publication Number Publication Date
ATE234920T1 true ATE234920T1 (de) 2003-04-15

Family

ID=27562887

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93924777T ATE234920T1 (de) 1992-11-17 1993-11-17 Aktivin-rezeptor-ähnliche kinasen, proteine mit serin/threonin kinase domänen und deren anwendungen

Country Status (10)

Country Link
US (5) US6316217B1 (de)
EP (1) EP0677104B1 (de)
JP (1) JP3362151B2 (de)
KR (1) KR950704485A (de)
AT (1) ATE234920T1 (de)
AU (1) AU683431B2 (de)
CA (1) CA2149441C (de)
DE (1) DE69332779T2 (de)
NZ (1) NZ257631A (de)
WO (1) WO1994011502A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592428B1 (en) * 1992-11-17 2009-09-22 Ludwig Institute For Cancer Research Antibodies which bind specifically to activin receptor like kinases
US6291206B1 (en) * 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
US6248554B1 (en) * 1993-11-24 2001-06-19 The Procter & Gamble Company DNA sequence coding for a BMP receptor
JPH10511840A (ja) 1994-04-29 1998-11-17 クリエイティブ バイオモレキュールズ，インコーポレイテッド 形態形成タンパク質特異細胞表面レセプターおよびその使用
US5614609A (en) * 1994-10-20 1997-03-25 Carlos F. Ibanez Serine threonine kinase receptor
US6306622B1 (en) 1994-11-04 2001-10-23 The Procter & Gamble Co. cDNA encoding a BMP type II receptor
US6210899B1 (en) 1994-11-04 2001-04-03 The Procter & Gamble Company Use of a BMP protein receptor complex for screening bone metabolism actives and cells co-transfected with a type II BMP receptor and type I BMP receptor
AU709991B2 (en) * 1995-08-14 1999-09-09 Creative Biomolecules, Inc. Binding of osteogenic protein-1 (OP-1) and analogs thereof to the cell surface receptor ALK-1 and analogs thereof
AU6421498A (en) * 1997-04-28 1998-11-24 Helix Research Institute Serine/threonine protein kinase
EP2078752A3 (de) * 1998-03-13 2009-09-23 Ludwig Institute For Cancer Research ALK-1 reagiert auf TGF-beta und gibt die Signale weiter mittels SMAD-1 und SMAD-5
WO2002094084A2 (en) * 2001-05-21 2002-11-28 University Of Iowa Research Foundation Bmpr1a involvement in juvenile polyposis
ATE437950T1 (de) * 2003-09-15 2009-08-15 Res Dev Foundation Cripto-antagonismus von activin und tgf-b signalisierung
WO2005077403A1 (en) * 2004-02-04 2005-08-25 Stryker Corporation Therapeutic methods using smads
US8410246B2 (en) 2004-06-17 2013-04-02 Thrasos, Inc. TDF-related compounds and analogs thereof
UA94060C2 (ru) 2005-09-07 2011-04-11 Эмджен Фримонт Инк. Моноклональное антитело, которое специфически связывает alk-1
EP1945258A4 (de) 2005-09-20 2011-08-17 Thrasos Therapeutics Inc Mit tdf verwandte verbindungen und analoga davon
RU2559532C2 (ru) * 2006-11-02 2015-08-10 Акселерон Фарма, Инк. Антагонисты рецептора и лигандов alk1 и их применение
US10059756B2 (en) 2006-11-02 2018-08-28 Acceleron Pharma Inc. Compositions comprising ALK1-ECD protein
US8642031B2 (en) 2006-11-02 2014-02-04 Acceleron Pharma, Inc. Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof
KR20110031908A (ko) 2008-05-02 2011-03-29 악셀레론 파마 인코포레이티드 혈관신생 및 혈관주위세포 적용범위의 조정을 위한 ａｌｋ１ 길항제 기재의 방법 및 조성물
US20100061976A1 (en) * 2008-07-24 2010-03-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject
CN107970445B (zh) 2009-03-30 2021-09-07 阿塞勒隆制药公司 Bmp-alk3拮抗剂和促进骨生长的用途
AU2013256094A1 (en) 2012-05-04 2015-01-15 The Board Of Regents Of The University Of Oklahoma Substrates and inhibitors of prolyl oligopeptidase and fibroblast activation protein and methods of use
MA41919A (fr) 2015-04-06 2018-02-13 Acceleron Pharma Inc Hétéromultimères alk4:actriib et leurs utilisations
KR20180002661A (ko) 2015-04-06 2018-01-08 악셀레론 파마 인코포레이티드 ALK7:ActRIIB 이형다합체와 이의 용도
CN105738630A (zh) * 2016-02-16 2016-07-06 林兴 丝/苏氨酸激酶抑制蛋白在治疗免疫性肝纤维化药物中的应用
CN105617369A (zh) * 2016-02-17 2016-06-01 林兴 丝/苏氨酸激酶抑制蛋白在治疗化学性肝纤维化药物中的应用
BR112019000790A2 (pt) 2016-07-15 2019-07-02 Acceleron Pharma Inc composições e métodos para tratar hipertensão pulmonar
BR112019000941A2 (pt) 2016-07-20 2019-04-30 Novartis Ag derivados de aminopiridina e seu uso como inibidores seletivos de alk-2
JP7219705B2 (ja) 2016-10-05 2023-02-08 アクセルロン ファーマ インコーポレイテッド ＡＬＫ４：ＡｃｔＲＩＩＢヘテロ多量体およびその使用
CN111433195B (zh) 2017-11-24 2023-04-25 诺华股份有限公司 吡啶酮衍生物及其作为选择性alk-2抑制剂的用途
WO2022046840A1 (en) * 2020-08-26 2022-03-03 Arizona Board Of Regents On Behalf Of The University Of Arizona Hybrid allosteric receptor-engineered stem cells
WO2023019185A1 (en) * 2021-08-10 2023-02-16 Gentibio, Inc. Compositions and methods for engineering stable tregs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587022T2 (de) * 1984-02-17 1993-06-17 Genentech Inc Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren.
AU3920693A (en) * 1992-03-18 1993-10-21 General Hospital Corporation, The Four novel receptors of the TGF-beta receptor family
AU683073B2 (en) * 1993-06-07 1997-10-30 Amgen, Inc. Hybrid receptor molecules
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
US6248554B1 (en) 1993-11-24 2001-06-19 The Procter & Gamble Company DNA sequence coding for a BMP receptor
JPH10511840A (ja) * 1994-04-29 1998-11-17 クリエイティブ バイオモレキュールズ，インコーポレイテッド 形態形成タンパク質特異細胞表面レセプターおよびその使用
US5614609A (en) * 1994-10-20 1997-03-25 Carlos F. Ibanez Serine threonine kinase receptor

Also Published As

Publication number Publication date
AU5432094A (en) 1994-06-08
EP0677104B1 (de) 2003-03-19
EP0677104A1 (de) 1995-10-18
DE69332779D1 (de) 2003-04-24
DE69332779T2 (de) 2003-10-23
US6331621B1 (en) 2001-12-18
AU683431B2 (en) 1997-11-13
WO1994011502A2 (en) 1994-05-26
US6982319B2 (en) 2006-01-03
CA2149441A1 (en) 1994-05-26
US20020123139A1 (en) 2002-09-05
WO1994011502A3 (en) 1994-07-07
US6316217B1 (en) 2001-11-13
US6207814B1 (en) 2001-03-27
JPH08505049A (ja) 1996-06-04
US6271365B1 (en) 2001-08-07
KR950704485A (ko) 1995-11-20
NZ257631A (en) 1996-03-26
CA2149441C (en) 2004-03-02
JP3362151B2 (ja) 2003-01-07

Similar Documents

Publication Publication Date Title
ATE234920T1 (de) Aktivin-rezeptor-ähnliche kinasen, proteine mit serin/threonin kinase domänen und deren anwendungen
BR9307646A (pt) Pirrolopirimidinas como antagonistas de crf
AR007856A1 (es) Compuestos heterociclicos fusionados como inhibidores de proteina tirosina, quinasa, sus metodos de prepraracion, intermediarios, uso en medicina ycomposiciones farmaceuticas que los contienen
MD1616G2 (ro) Compuşi triciclici şi metodă de inhibare a receptorului tirozin kinazei pentru factorul de creştere epidermic, compoziţie farmaceutică, metode de prevenire a implantării blastocitului şi tratament al mamiferelor
AR007857A1 (es) Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios uso en medicina ycomposiciones farmaceuticas que los contienen.
BRPI0111222B8 (pt) derivados fosfonados de glicopeptídeo.
AR007855A1 (es) Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios, uso en medicinay composiciones farmaceuticas que los contienen
FR2678615B1 (fr) Benzofuranne-2-ones thiomethylees, leur preparation et leur application comme stabilisants de matieres organiques.
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
PT1017384E (pt) Compostos com base no azabenzimidazole para modulacao da funcao de uma cinase de proteina serina/treonina
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
FI971953A0 (fi) Proteiinityrosiinikinaasin välittämää soluproliferaatiota inhiboivat 6-aryyli-pyrido(2,3-d)pyrimidiinit ja naftyridiinit
AU5580496A (en) Domains of extracellular region of human platelet derived growth factor receptor polypeptides
FI961236A0 (fi) K-252a-johdannaisia, jotka lisäävät neurotrofiinin aiheuttamaa aktiivisuutta
AU1557400A (en) Absorbent elements for hygiene articles
SE9700606L (sv) Vätskegenomsläppligt höljesskikt till absorberande alster
BR0003474A (pt) Artigo absorvente compreendendo fibras floculadas
DE59601878D1 (de) Verwendung von schwerflüchtigen pyrazolderivaten mit hydrophilen gruppen als nitrifikationsinhibitoren
PE26499A1 (es) Capa de adquisicion de liquido para articulos absorbentes
YU78092A (sh) Postupak za dobijanje derivata beta-fenilizoserina i njihova primena
ES2096615T3 (es) Compuestos tensioactivos de triazina, procedimiento para su preparacion y su utilizacion.
ES2171743T3 (es) Derivados de amidinas e isotioureas como inhibidores de la enzima sintasa de oxido nitrico.
ES2171697T3 (es) Antagonistas del receptor de endotelina.
NO913096D0 (no) Fremgangsmaate for fremstilling av formlegemer av silisiuminnfiltrert silisiumkarbid.
DE69015344T2 (de) Phosphatzusammensetzungen, gesinterter Körper davon und Herstellung dieses gesinterten Körpers.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties